Evidence that the difference in kidney graft survival in DRw6+ and DRw6- recipients may be explained by a blood transfusion policy that is disadvantageous for DRw6+ recipients

Transplantation. 1987 Dec;44(6):788-91. doi: 10.1097/00007890-198712000-00013.

Abstract

Kidneys transplanted to HLA-DRw6+ recipients have been shown to have an inferior graft survival compared with DRw6- patients. Because pretransplant blood transfusions influence kidney graft survival, we investigated whether the number of blood transfusions contributes to the observed poor graft survival in DRw6+ patients. We have found that the difference in graft survival in DRw6+ and DRw6- recipients may be explained by a blood transfusion policy that is disadvantageous for DRw6+ recipients. Thus, graft survival in DRw6+ recipients was excellent for those who had received only a single transfusion. More transfusions resulted in a gradual decrease in graft survival. When the number of transfusions exceeded 5, graft survival improved again. By contrast, DRw6- recipients showed an improvement in graft survival with an increasing number of transfusions. DRw6+ recipients therefore display inferior graft survival only when they receive 3-5 transfusions. This finding provides a possible explanation as to why the "DRw6 effect" is a controversial issue, and it suggests that DRw6+ recipients should be given a different pre-transplant transfusion protocol than DRw6- patients.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclosporins / therapeutic use
  • Graft Enhancement, Immunologic* / adverse effects
  • Graft Survival* / drug effects
  • HLA-D Antigens / immunology*
  • HLA-DR Antigens / immunology*
  • HLA-DR6 Antigen
  • Histocompatibility
  • Humans
  • Immunization
  • Kidney Transplantation*
  • Prognosis
  • Transfusion Reaction*

Substances

  • Cyclosporins
  • HLA-D Antigens
  • HLA-DR Antigens
  • HLA-DR6 Antigen